HomeInsightsMarket Capitalization

Market Capitalization of Remus Pharmaceuticals Ltd

Market Capitalization of Remus Pharmaceuticals Ltd

stocks purchased

₹ 0.7 Cr

Volume transacted

stocks purchased

2.8 K

stocks traded

Last Updated time: 05 Nov 9.00 AM

Image

Remus Pharmaceuticals Ltd

NSE: RemusPharma.

MARKETCAP

1498.1 crore

Last updated on: Nov 04, 2024

Key Highlights

  • The Market Cap of Remus Pharmaceuticals Ltd is ₹ 1498 crore as of 04 Nov 24.
  • The Market Cap of Remus Pharmaceuticals Ltd is ₹ 1016 crore as of March 2024.
  • The Latest Trading Price of Remus Pharmaceuticals Ltd is ₹ 2542 as of 04 Nov 15:30.
Image

Remus Pharmaceuticals Ltd

NSE: RemusPharma.

MARKETCAP

1016.27 crore

Last updated on: Invalid Date

Company Fundamentals for Remus Pharmaceuticals Ltd

No data available

Image

Remus Pharmaceuticals Ltd

NSE: RemusPharma.

PRICE

2542.6

-89.70 (-3.41%)

stock direction

Last updated on: Nov 04 03:30 PM

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Remus Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
04 Nov 20242542.6
01 Nov 20242632.3
31 Oct 20242616.7
30 Oct 20242598.75
29 Oct 20242571.45
28 Oct 20242441
25 Oct 20242404.75
24 Oct 20242449
23 Oct 20242481.8
22 Oct 20242549.7

SWOT Analysis Of Remus Pharmaceuticals Ltd

Strength

4

S

Weakness

3

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Remus Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Remus Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Remus Pharmaceuticals Ltd

No data available

Historical P/E Ratio of Remus Pharmaceuticals Ltd

No data available

* All values are in %

Historical Revenue of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payout of Remus Pharmaceuticals Ltd

No data available

* All values are in %

About Remus Pharmaceuticals Ltd

  • Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited' as a private limited company, vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat.
  • Subsequently, Company converted from a private company to public company and consequently, the name of Company was changed to 'Remus Pharmaceuticals Limited' on January 06, 2023 by the Registrar of Companies, Ahmedabad. The Company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs.
  • It deals in API (Active Pharmaceutical Ingredient), provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries.
  • The Company deal in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet.

Remus Pharmaceuticals Ltd News Hub

News

Remus Pharmaceuticals to convene AGM

Remus Pharmaceuticals announced that the 9th Annual General Meeting (AGM) of the company w...

Read more

31 Aug 202415:40

News

Remus Pharmaceuticals to table results

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 16 M...

Read more

10 May 202412:07

News

Remus Pharmaceuticals schedules EGM

Remus Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Compan...

Read more

24 Apr 202410:34

News

Remus Pharmaceuticals revises board meeting date

Remus Pharmaceuticals has revised the meeting of the Board of Directors which was schedule...

Read more

20 Apr 202415:16

News

Remus Pharmaceuticals to consider Dividend

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 22 A...

Read more

17 Apr 202409:39

News

Board of Remus Pharmaceuticals recommends interim dividend

Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting ...

Read more

20 Oct 202316:09

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Remus Pharmaceuticals Ltd Market Cap

What is the market cap of Remus Pharmaceuticals Ltd?

As of November 5, 2024, Remus Pharmaceuticals Ltd has a market capitalization of ₹1498.1, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Remus Pharmaceuticals Ltd's market capitalization?

Remus Pharmaceuticals Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Remus Pharmaceuticals Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Remus Pharmaceuticals Ltd's market capitalization change?

Remus Pharmaceuticals Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*